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Acute lymphoblastic leukemia (ALL) is one of the most common forms of malignancy that
occurs in lymphoid progenitor cells, particularly in children. Synthetic steroid hormones
glucocorticoids (GCs) are widely used as part of the ALL treatment regimens due to their
apoptotic function, but their use also brings about various side effects and drug resistance.
The identification of the molecular differences between the GCs responsive and resistant
cells therefore are essential to decipher such complexity and can be used to improve ther-
apy. However, the emerging picture is complicated as the activities of genes and proteins
involved are controlled by multiple factors. By adopting the systems biology framework to
address this issue, we here integrated the available knowledge together with experimen-
tal data by building a series of mathematical models. This rationale enabled us to unravel
molecular interactions involving c-Jun in GC induced apoptosis and identify Ets-related
gene (Erg) as potential biomarker of GC resistance. The results revealed an alternative
possible mechanism where c-Jun may be an indirect GR target that is controlled via an
upstream repressor protein. The models also highlight the importance of Erg for GR func-
tion, particularly in GC sensitive C7 cells where Erg directly regulates GR in agreement
with our previous experimental results. Our models describe potential GR-controlled mol-
ecular mechanisms of c-Jun/Bim and Erg regulation. We also demonstrate the importance
of using a systematic approach to translate human disease processes into computational
models in order to derive information-driven new hypotheses.
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INTRODUCTION
Acute lymphoblastic leukemia (ALL) refers to a cancer of T- or B-
lymphoid progenitor cells, which is found to be the most common
childhood malignancy (Pui et al., 2008). Despite the 85–90% cure
rate in children (Onciu, 2009), a quarter of the cases suffer relapse,
with drug resistance being a major cause (Mullighan et al., 2011).
Glucocorticoids (GC) have been used as part of the treatment of
many diseases including ALL, owing to their anti-inflammatory
and anti-cancerous actions (Schaaf and Cidlowski, 2002). One of
the main causes for resistance to GC is the defective signaling of
GC to target genes in relation to apoptosis.
The principle of GC therapy in ALL is GC induced apoptosis,
whereby GC activates the glucocorticoid receptor (GR) that upon
hormone binding translocates to the nucleus and targets the apop-
tosis mediating family, the B-cell lymphoma 2 (Bcl-2). The Bcl-2
member Bim is known to be an essential initiator of apoptosis
(Wang et al., 2003; Abrams et al., 2004; Ploner et al., 2007; Zhao
et al., 2011) and an indirect GR target (Wang et al., 2003). The
GR regulation of Bim in ALL is however not fully defined; it was
reported that c-Jun may be a potential candidate for targeting Bim
Abbreviations: AP-1, activator protein 1; Bcl-2, B-cell lymphoma 2; Dex, dexam-
ethasone; Erg, Ets-related gene; GC, glucocorticoid; GR, glucocorticoid receptor;
GRE, glucocorticoid response element; ODE, ordinary differential equations.
activation (Zhou and Thompson, 1996; Lu et al., 2006; Biswas et al.,
2007; Chen et al., 2012). Apart from the Bcl-2 family members, we
and others recently reported that the Ets protein, Ets-related gene
(Erg) is induced by GC in the resistant ALL CEM C1–15 cells and
may be a crucial GR target for determining GC resistance (Geng
and Vedeckis, 2005; Baldus et al., 2006; Thoms et al., 2011; Tsuzuki
et al., 2011).
Although recent high throughput technologies have advanced
the understanding of complex gene regulatory mechanisms, it is
important to note that complex molecular mechanisms cannot be
deciphered using experimental data alone. Considering the wide
range and large volume of presented data and information about
GR, Bim, and Erg, computational modeling can be considered as
an effective strategy for the interpretation of such data from var-
ious sources (Hoffmann et al., 2002; Faratian et al., 2009; Chen
et al., 2010). In addition, modeling using time-course data not
only raises the prospect of inferring the existence of causal rela-
tionships between genes, but also of identifying the direction of
causality from the regulated genes (Sayyed-Ahmad et al., 2007).
Among various modeling approaches, ordinary differential equa-
tions (ODE) have been widely used for studying the dynamics of
gene networks. They offer the advantages of maintaining the quan-
titativeness and causality inherent in dynamical systems equations
while being computationally manageable for small systems.
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FIGURE 1 |Topology of GR/Jun/Bim models in CEM C7–14 cells
Schematic representation of GR inducing Bim via c-Jun. The figure
summarizes the basic mechanism of Bim regulation controlled by GR. The
model topology was based on (Chen et al., 2010, 2012), where glucocorticoid
passes through the cell membrane, causes GR activation by dissociating GR
from the cytoplasmic heat shock protein (HSP) complex. The bound GR
dimerizes, either activates or represses its target genes through binding to
GREs in the target genes or via the recruitment of other transcription factors.
All models were constructed by CellDesigner, based on the known or
potential molecular mechanisms but without taking the cytoplasmic-nuclear
compartmentalization into account. Basal transcription, GR autoregulation,
mRNA degradation, protein degradation, and binding dynamics were included
in the models and the reactions were described using first order mass action
kinetics. The details of the kinetic equations in all models are described in
Appendix. (A) Model 1 represents GR induces Bim activation via direct
binding to c-Jun. (B) Model 2 is similar to Model 1 but differs by the nature of
the interaction between the GR and c-Jun. An extra step of protein synthesis
was introduced for targeting down-stream target gene c-Jun in Model 2.
Recently we have proposed a series of ODE kinetic models
for GR regulation by integrating time series of gene and protein
expression data with kinetic modeling through information the-
ory (Chen et al., 2010). We identified crucial time points that
distinguish early GC and delayed GC response genes. To develop
a more global understanding of GR action, we have extended this
investigation to new time points and examined time-dependent
GR-regulated genes with gene expression microarray. Time-course
gene expression clustering led to further identification of crucial
genes c-Jun and Erg as potential biomarkers for GC resistance
(Chen et al., 2012).
Here we present extended models of GR regulation of c-Jun,
Bim, and Erg based on a set of ODE (Chen et al., 2010). Several
possibilities for interactions between GR and the selected genes
were analyzed and the models that led to the best agreement with
the experimental response were identified. We sought to show how
our models can be further adapted to integrate and study GC regu-
lated gene expression time series and obtain better understanding
toward the regulatory mechanisms between GR, c-Jun, Bim, and
Erg in leukemia (Figure A1 in Appendix).
MATERIALS AND METHODS
PROTEIN AND mRNA EXPRESSION MEASUREMENTS
Time-course protein and mRNA measurements were performed
according to the methods described previously (Chen et al., 2010).
In brief, CCRF-CEM-C1-15 ALL cells resistant to GCs and CCRF-
CEM-C7-14 ALL cells sensitive to GCs were plated in six-well
plates in RPMI-1640 supplemented with 10% DCC-FBS and incu-
bated overnight. 1µM of dexamethasone (Sigma, MO, USA),
10µM YK-4-279, or 10µM JNK inhibitor II (SP600125) were
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added to the medium and cells were incubated for 0, 2, 10, and
48 hours (h) accordingly. The relative protein expression was then
measured and calculated via immuno-blotting using the ImageJ
software, with actin as a control due to its ubiquitous expression
in eukaryotic cells and its known property of being indepen-
dent of GC treatment (Davies et al., 2008; Adzic et al., 2009).
GR (H-300), c-Jun (H79), and Erg (D-3) antibodies were pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA, USA);
Actin and Bim antibodies were purchased from Abcam (Cam-
bridge, UK). A detailed protocol and list of chemicals can be
found in (Chen et al., 2010, 2012). The relative mRNA levels were
measured using quantitative real time PCR analysis with the Bio-
Rad Chromo4 system (Opticon monitor 3 software version 3.1)
using the standard curve method with a known housekeeping gene
RPL-19 as the control, which is not affected by GC (Rogatsky
et al., 2003; Park et al., 2007; list of primer sequences: Rpl-19: F:
ATGTATCACAGCCTGTACCTG; R: TTCTTGGTCTCTTCCTC-
CTTG; Bim: F: GAGAAGGTAGACAATTGCAG; R: GACAAT-
GTAACGTAACAGTCG; GR: F: GTTGCTCCCTCTCGCCCT-
CATTC; R: CTCTTACCCTCTTTCTGTTTCTA; c-Jun: F: ACT-
GCAAAGATGGAAACGAC; R: AAAATGTTTGCAACTGCTGC;
Erg: F: CAATCTCGAGCTATGGCCAGCACTATTAAGGAAGC; R:
CAATCCCGGGTTAGTAGTAAGTGCCCAGATGAGAAG). Briefly,
the total RNA was extracted from approximately 5× 106 cells
with the RNeasy plus mini kit (Qiagen) and was used to gener-
ate cDNA using the Reverse-iT RTase kit following the two-step
protocol (ABgene) according to the manufacturer’s guidelines. The
cDNA was serially diluted and used for qPCR with SensiMix SYBR
No-ROX Kit (Bioline) and the indicated primers. Thermocycle
conditions were set with the Bio-Rad Chromo4 system (Opticon
monitor 3 software version), including initial denaturation at 95˚C
(10 min), followed by 35 cycles at 95˚C (30 s), 50˚C (30 s) and 72˚C
(1 min). A melting curve was calculated from 72˚C to 95˚C with
1˚C increase every 30 s. Standard curves were generated by plot-
ting the CT vs. the log
copies
10 of serially diluted PCR products in
order to determine the copy number of amplified DNA. All results
are reported as mean± SD unless otherwise noted. The Tukey’s
multiple comparison test and Student t -test were carried out to
analyze western and qRT-PCR using SPSS 16.0 (SPSS Statistics).
SIGNALING NETWORK REPRESENTATION
To construct the GR/c-Jun/Bim and GR/Erg pathways, literature
information was used to assemble the signaling topologies. As
described previously and in (Lu et al., 2006), GR activates Bim
through an indirect mechanism in C7 cells, potentially through
either direct or indirect c-Jun activation. Two models were built to
represent GR/c-Jun/Bim in C7 cells, which differ by the involve-
ment of an additional set of unknown protein X synthesis (Models
1 and 2). We have previously identified an increase in Erg expres-
sion in GC resistant C1 cells in response to GC treatment, and this
was not found in GC sensitive C7 cells. In C1 cells, GR/Erg models
were defined as Erg being either a direct or an indirect GR target
(Models 3 and 4); a potential GC response element was identified
via the champion ChiP transcription factor search portal which is
a text mining tool based on SABiosciences’database Decipherment
of DNA element (DEDCODE). In C7 cells, although there were no
significant changes in Erg expression, we did find a transient Erg
recruitment on the GR promoter after 2 h of GC treatment. This
highlights the potential role of Erg in regulating GR transcrip-
tion. For this reason we constructed two models, one including
only GR autoregulation in C7 cells (Ramdas et al., 1999; Schmidt
et al., 2006), the other including both GR autoregulation and Erg
regulation of GR transcription (Models 5 and 6). Therefore, we
present six models, including two models representing GR reg-
ulation on c-Jun and Bim in C7 cells, two models for the Erg
control of GR autoregulation in C7 cells and two models showing
Erg being either a direct or indirect GR target in C1 cells. The
network models were implemented using the CellDesigner soft-
ware (www.celldesigner.org; Funahashi et al., 2003, 2008). Protein
and mRNA degradation and basal synthesis rates were included
in all models using mass action kinetics, without taking cellular
translocation into consideration.
PARAMETER ESTIMATION AND SIMULATION
All parameter estimations were performed using the Systems Biol-
ogy Markup Language-based parameter estimation tool (SBML-
PET; Zi and Klipp, 2006), which relies on the sets of ODE asso-
ciated to model reactions and on the obtained experimental data.
As shown in (Pedersen et al., 2004), GR has a relatively slow
protein half-life between 27–42 h in the absence or presence of
Dex, with a kinetic parameter of 0.0165–0.0257 h−1 (parame-
ter k = ln(2)/protein half-life). For this reason, parameters were
constrained between 0.01 and 1 for the estimation process. Once
the estimated parameters were obtained, model simulations were
then carried out using the CellDesigner software. Least-square
residual values (ε) were calculated as seen in Chen et al., 2010 in
order to determine the quality of the fit between simulations and
experimental data.
ε =
√√√√ 1
n
n∑
i = 1
(
yi − Yi
Yi
)2
where ε is the residual,n is the number of experimental data points,
y i are the experimental values, and Y i are the simulated values of
the variable under consideration.
RESULTS
MODELING GR REGULATION OF BIM VIA C-JUN ACTIVATION IN GC
SENSITIVE C7 CELLS
GR induced apoptosis occurs through an intrinsic mitochondria
dependent pathway via regulation of BCL-2 family proteins. In
particular, the pro-apoptotic member Bim (BCL-2 interacting
mediator of cell death) is known to be upregulated in sensitive
ALL cells upon treatment with Dex through an indirect mecha-
nism and plays a crucial role in apoptosis (Wang et al., 2003; Ploner
et al., 2007; Chen et al., 2010). However, the molecular mechanism
for Bim induction by GR is unclear. We and other have previously
identified that c-Jun may be involved in the upregulation of Bim
by GR (Zhou et al., 2000; Chen et al., 2010). Compared to the
known direct GR target BclXL, both c-Jun and Bim were induced
by GR much later, as a dramatic induction was observed between
6–10 h, suggesting a potential delayed and indirect GR induced
activation mechanism (Chen et al., 2010). However, we cannot
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FIGURE 2 | Simulations of GR/Jun/Bim induction in CEM C7–14 cells.
The simulation process and the experimental data were described in our
previous work (Chen et al., 2010, 2012). In brief, the expression dynamics
were simulated with the use of CellDesigner and SBML-PET parameter
estimation tool based on the experimental data obtained at 0, 2, and 10 h
after 1µM dexamethasone (Dex) treatment (Chen et al., 2012). Solid
squares are the mean of the normalized experimental data and bars are
the SDs for three sets of experiments. The simulation process is divided to
two steps, the parameters for GR activation alone were first obtained
(dotted line), and then the rest of the parameters were estimated based
on the individual model topologies. The black solid line represents the
simulation by Model 1 and the blue solid line is the simulation of Model 2
(A) Protein time-course simulations of GR, c-Jun, and Bim in CEM C7–14
cells. (B) The simulations for GR, c-Jun, and Bim mRNA dynamics. The
models as shown revealed the characteristic kinetics of GR, c-Jun, and
Bim in response with Dex in CEM C7–14 cells. The residual value was
calculated to assess the quality of the fit between the simulations and the
experimental data.
rule out the possibility that GR may induce c-Jun directly, as a
putative GC response element was found at −1.6 kbp from the c-
Jun promoter (Jonat et al., 1990). We also found two potential GR
binding sites with the use of DECODE (Table A1 in Appendix). A
schematic diagram of GR inducing c-Jun is presented in Figure A2
in Appendix.
To model GR induced Bim activation, we considered two
scenarios, involving either c-Jun being directly activated by GR
before activating Bim (Model 1), or c-Jun being indirectly acti-
vated through de novo protein synthesis of an unknown protein
X (Model 2; Figures 1A,B). The experimental data used for
parameter simulation were taken from previous results (Chen
et al., 2012), where protein and mRNA expression series were
obtained after treatment with 1µM Dex for 2 and 10 h in addi-
tion to the control (0 h). Model topologies were constructed via
CellDesigner, with the inclusion of basal synthesis, protein, and
mRNA degradation which were described by mass action kinet-
ics; the equations used in the model are presented in Appendix.
Cellular translocation and compartmental levels were not taken
into account in the models. The unknown parameters were esti-
mated from the defined topologies and the experimental data
in combination with the use of SBML-PET. Due to the absence
of quantitative data of most signaling components, we carried
out the parameter estimation procedure in two parts: GR basal
synthesis, protein, and mRNA degradation were estimated firstly,
followed by the rest of unknown parameters. Figure 2 shows
experimental and simulated time-courses using Models 1 and
2 of GR, c-Jun, and Bim protein and mRNA levels. All mRNA
and proteins show induction but the simulation with Model 2
exhibited a more similar trend to our previous results (Chen
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FIGURE 3 |Topology of GR/Erg models in CEM C7–14 cells. Schematic
representation of GR/Erg pathway. The nature of the topologies was based on
previously established direct GR target model (Chen et al., 2010). Model 3 and
Model 4 are similar and only differ by the regulation of GR, in Model 3 GR
regulation is controlled by GR itself (A) whereas in Model 4 GR regulation is
controlled by both GR itself and Erg direct interaction to GR gene (B).
et al., 2010, 2012), where a logarithmic tendency was seen. This
observation is crucial since we have previously shown that direct
and indirect GR targets can be distinguished based on the sim-
ulation trend, where direct GR targets exhibit a linear trend
and indirect GR targets behave closer to a logarithmic func-
tion, due to the time delay required for the upstream pathway
to be activated. At the protein level, Bim simulation seemed to
fit better with Model 2, with an increase of up to 7.4-fold at
24 h and a smaller least-square residual value (ε= 0.2605) com-
pared to Model 1 (17.18-fold at 24 h, ε= 0.6969; Figure 2A).
In contrast, c-Jun protein simulation with Model 1 fits better
(13.9-fold at 24 h, ε= 0.4997) than Model 2 (28.1-fold at 24 h,
ε= 0.8338), particularly after 10 h of treatment (Model 1: 4.5-fold
at 10 h; Model 2: 6.2-fold at 10 h). Compared to the simula-
tions of protein levels, mRNA simulations with both Model 1
and Model 2 seemed to fit better with the experimental data
(Figure 2B). A logarithmic shaped mRNA simulation of both
Bim and c-Jun was seen with Model 2 only, in contrast an
almost linear increase of Bim mRNA simulation was observed
with Model 1. Least-square residual values in both models were
much closer to each other for mRNA than proteins [Model 1:
c-Jun (ε= 0.3241), Bim (ε= 0.1471); Model 2: c-Jun (ε= 0.2276),
Bim (ε= 0.1891)].
MODELING THE ROLE OF ERG IN GR GENE EXPRESSION IN GC
SENSITIVE C7 CELLS
We have previously characterized the kinetic response to GR in
ALL through time-course clustering of gene expression microar-
ray (Chen et al., 2012). Results from the experiments and analyses
identified Erg as one of the crucial genes that determine GC
resistance. In addition, chromatin immunoprecipitation results
showed that Erg was transiently recruited on the GR1A pro-
moter in sensitive C7 cells only. Erg is a member of the Ets
transcription factor family which has been linked to growth of
hematopoietic cells and fusion with genes that are involved in
cancer, such as the EWS gene in Ewing’s sarcoma (Sorensen
et al., 1994; Tsuzuki et al., 2011). It has recently been identi-
fied as a prognosis factor in T-ALL and prostate cancer (Nam
et al., 2007; Thoms et al., 2011; Tsuzuki et al., 2011). Ets sub-
family members have also been linked to GR regulation in ALL
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(Geng and Vedeckis, 2005; Baldus et al., 2006; Figure A2 in
Appendix).
To systematically assess the factors of resistance to GC therapy
in CEM cells, we developed kinetic models of GR/Erg signaling.
As GR was recruited on the GR promoter in C7 cells, we sought
to build a model that can capture the effect of Erg on GR expres-
sion and verify our experimental results. We here constructed two
models, with Model 3 and Model 4 differing by Erg regulation on
GR (Figures 3A,B). Both models captured GR and Erg transcrip-
tion, translation, and degradation and each reaction was described
by mass action kinetics (Appendix). The regulation between Erg
and GR expression is not only an important component of GR
homeostasis, but also a potential factor provoking GC resistance
in relation to the level of GR. The simulations showed that Model
4 overall fits better our experimental results, where microarray,
western, and qRT-PCR analysis identified a low level of Erg (≤1-
fold) and an increase of GR (protein simulation increased up to
4.4-fold and mRNA up to 27.5-fold), although GR induction was
smaller compared to GR simulations in Model 3 (with both protein
and mRNA simulation exceeding 140-fold-change at 24 h). This is
particularly apparent at the Erg mRNA level, in comparison with
the low level of Erg mRNA simulation in Model 4, an increase
was observed in Model 3 (4.3-fold at 24 h; Figures 4A,B). In addi-
tion, in Model 4 the simulation of both Erg protein and mRNA
level decreased after 4 h of Dex treatment before gradually reach-
ing a steady state (protein simulation: 0.9-fold, mRNA simulation
0.2-fold). At the protein level, least-square residual values for GR
(ε= 1.1880) and Erg (ε= 0.4218) were both higher in Model 3
than in Model 4 (GR: ε= 0.2758; Erg: ε= 0.1874), with GR show-
ing a greater discrepancy in comparison with the other compo-
nents. The residual values of GR and Erg mRNA simulations were
lower than their protein simulations in both Model 3 and Model
4, ranging between 0.3 and 0.5 (Model 3: GR: ε= 0.4058; Erg:
ε= 0.3665; Model 4: GR: ε= 0.3896; Erg: ε= 0.5852). Altogether it
seemed that Model 4 simulations and analysis corroborated earlier
findings (Chen et al., 2012), which further confirms that this model
is more appropriate. These results also highlight the importance
of the role of Erg expression on GR regulation.
FIGURE 4 | Simulations of GR/Erg pathway in CEM C7–14 cells.
(A) Protein time-course simulation of GR/Erg pathway in CEM C7–14
cells. The same process of simulation was carried out in Model 3 and
Model 4 as described in Figure 2. Solid squares are the experimental
data and the error bars are means±SD for three sets of experiments.
The black solid line represents the simulation by Model 3 and the blue
solid line is the simulation of Model 4. The residual value was
calculated to assess the quality of the fit between the simulations
and the experimental data. (B) GR and Erg mRNA time-course
simulations in CEM C7–14 cells.
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MODELING THE ROLE OF ERG IN GR GENE EXPRESSION IN GC
RESISTANT C1 CELLS
In the next step, we sought to investigate the GR dependent Erg
induction that was previously found in resistant C1 cells only.
Treatment with Dex was found to induce Erg expression in C1
cells and an increase of apoptosis was observed when treated with
Erg inhibitor (Chen et al., 2012). GR may be able to directly
activate Erg, as a potential GRE was identified on the Erg pro-
moter (Table A1B in Appendix). Based on the experimental data
obtained and strategy outlined above, we created two models for
the GR induced Erg expression (Figure 5). Similar to the direct
and indirect models as established in (Chen et al., 2010), the
two models differed by an extra step of de novo protein synthesis
(Figures 5A,B); the positive GR autoregulation feedback loop was
not included in C1 cells (Ramdas et al., 1999; Schmidt et al., 2006;
Chen et al., 2010).
The overall simulations with both direct (Model 5) and indirect
models (Model 6) showed an induction in both GR and Erg protein
and mRNA levels (Figures 6A,B). At the protein level, GR protein
simulations showed an increase of ≥15-fold with both models
whereas protein simulation with Model 6 increased at a much
lower rate in comparison (2.3-fold at 24 h) with Model 5. Erg pro-
tein simulation with Model 5 seemed to fit better than Model 6,
with the simulation clearly showing a better fit to the experimental
data. Despite the consistent upregulating simulation trends com-
pared with the experimental results, least-square analysis showed
that apart from Erg with Model 5 (ε= 0.6486), the residual values
were all greater than 1 [Model 5: GR (ε= 1.5566) and Model 6: GR
(ε= 1.0605), Erg (ε= 1.3059)]. In contrast to protein simulations,
mRNA simulations were found to have a good fit to the experimen-
tal data with both models, where GR and Erg mRNA were both
induced. The mRNA simulations with both models appeared to
increase at a slower rate in comparison with the protein simula-
tions; in Model 5 GR mRNA increased up to 13.6-fold and Erg
mRNA up to 2.3-fold at 24 h, whereas Model 6 showed a lower
increase rate with GR mRNA (5.4-fold) but a higher and more
linear induction in Erg mRNA (17.9-fold). Much smaller resid-
ual values were calculated at the mRNA levels, with Model 5 (GR:
FIGURE 5 |Topology of GR/Erg models in CEM C1–15 cells. Schematic
representation of GR/Erg pathway in CEM-C1–15 cells. The nature of the
topologies was based on previously established direct and indirect GR target
models in CEM-C1–15 cells (Chen et al., 2010). GR autoregulation was not
included in CEM-C1–15, Model 5 and Model 6 differ by the GR regulation on
Erg induction, with Model 5 indicating Erg as a direct GR target (A) and Model
6 showing Erg as an indirect GR target where de novo protein synthesis is
required for Erg induction (B).
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FIGURE 6 | Simulations of GR/Erg pathway in CEM C1–15 cells. The
same process of simulation was carried out in Model 5 and Model 6 as
described in Figure 2. Solid squares are the experimental data and the
error bars are means±SD for three sets of experiments. The black solid
line represents the simulation by Model 5 and the blue solid line is the
simulation of Model 6. (A) Protein time-course simulation of GR/Erg
pathway in CEM-C1–15 cells. (B) GR and Erg mRNA time-course
simulations in CEM-C1–15 cells.
ε= 0.2346, Erg: ε= 0.3856) having a better fit than Model 6 (GR:
ε= 0.4034, Erg: ε= 0.6590). These findings support the hypoth-
esis that GR may activate Erg expression by directly targeting the
GRE on the Erg promoter.
DISCUSSION
Glucocorticoids play a pivotal role in the treatment of ALL through
initiating apoptosis. Despite the relatively high cure rate, GC resis-
tance still remains a therapeutic problem due to its unknown
molecular mechanism. Thanks to advances in “omics” technolo-
gies, there is a growing amount of literature and molecular
models addressing GC induced signaling. Bim, a well known pro-
apoptotic Bcl-2 member, has been identified as a crucial player
in apoptosis and is able to trigger cell death (Ploner et al., 2007).
It is known that Bim is activated by GR via an indirect mech-
anism where de novo protein synthesis is required (Wang et al.,
2003). Nevertheless, the exact mechanism of Bim induction by GR
is poorly understood. Forkhead box subgroup O3a (Foxo3a) has
been suggested as a potential candidate for targeting and activat-
ing Bim, thereby initiating apoptosis in chronic myeloid leukemia
(Essafi et al., 2005). This however may not be the case in ALL as
we observed an upregulation of Bim and GILZ in C7 cells, but not
of Foxo3 (Chen et al., 2010, 2012). GILZ can protect ALL cells by
provoking nuclear exclusion of Foxo3 (Latré de Laté et al., 2010),
which may also occur in ALL and further supports the idea that an
alternative protein is involved in Bim induction (Lu et al., 2006).
Time-course microarrays in ALL (Chen et al., 2012) and a study
of Bim in neuronal cells (Biswas et al., 2007) had led us to hypoth-
esize that c-Jun may be a crucial player in Bim activation. On the
other hand, Erg has recently been identified as a crucial prognosis
factor for determining GC resistance (Tsuzuki et al., 2011). We
have verified these results and found that Erg signaling may be
involved in GR regulation with a cell specific mechanism (Chen
et al., 2012).
Our ODE models of GR induced apoptosis capture the dynam-
ics of GR regulation of Bim via c-Jun and the crosstalk between
GR and Erg. For GR/c-Jun/Bim regulation, two possible topolo-
gies were constructed, where the two models differed by the nature
of the de novo protein synthesis (Figures 1A,B). Simulation out-
comes of GR interaction with c-Jun and Bim were consistent
Frontiers in Physiology | Systems Biology November 2012 | Volume 3 | Article 410 | 8
Chen et al. GR mediated Erg/c-Jun transduction
with the available biological data, where GR induced c-Jun and
Bim over time (Zhou and Thompson, 1996; Zhao et al., 2011).
Least-square analysis showed that c-Jun mRNA and Bim protein
in Model 2 fitted better with the experimental data whereas c-Jun
protein and Bim mRNA fitted better with Model 1 (Figures 2A,B).
These results may be explained by an involvement of alternative
mechanisms, as treatment with the protein synthesis inhibitor
cycloheximide has shown that c-Jun expression was not affected
and the induction became more prominent. Further nuclear run
on tests have indicated that c-Jun induction requires at least 6 h
after Dex treatment. This process takes much longer than the time
required for GR translocation and binding to the promoter of the
target gene, as previous green fluorescent protein experimentation
indicated that a full GR translocation takes only 2 h to complete
(Htun et al., 1996). It was suggested that the mechanism for the
delayed c-Jun induction may be secondary, potentially through
the relief from a protein repressor of transcription (Zhou et al.,
2000). Our previous chromatin immunoprecipitation results had
revealed c-Jun recruitment on the Bim promoter, which was not
repressed by inhibition of c-Jun N-terminal kinases (JNKs); in fact
apoptosis was enhanced in C7 cells despite Bim expression being
reduced (Figure A3A in Appendix; Lu et al., 2006; Chen et al.,
2012), suggesting an alternative signaling pathway for c-Jun induc-
tion. Several potential mechanisms of GR-regulated Bim induction
have been suggested, including the MAPK pathway (Morton et al.,
2003; Lu et al., 2006; Dobreva et al., 2009; Rahim et al., 2011).
Another subject of special interest to this study was to inves-
tigate the role of Erg in determining GC resistance, since we
identified Erg recruitment on the GR promoter in C7 cells only
but a substantial Erg expression was found in resistant C1 cells
(Chen et al., 2012). Since the relation between GR and Erg remains
obscure, we aimed to evaluate the role of Erg in the GR signaling
pathway, which could be modulated in a cell dependent manner.
Our GR/Erg models were devised into four sets, with two potential
mechanisms each tested in C7 and C1 cells.
To place Erg in the GR induction model in C7 cells, we consid-
ered the regulatory influence of Erg on GR autoregulation. Based
on previous literature and the finding of Erg recruitment on the GR
promoter, we hypothesized that Model 4 with direct Erg regulation
on GR expression would show a better fit with the experimental
data than Model 3 (Figures 3A,B; Geng and Vedeckis, 2005; Chen
et al., 2012). Indeed, simulations with Model 4 showed an increase
in GR mRNA and protein levels, and more importantly a low level
of Erg protein and mRNA, despite that a more dramatic increase
of GR protein and mRNA levels were identified in Model 3 simu-
lations (Figures 4A,B). Preliminary western blotting based on two
sets of independent experiments confirmed the potential role of
Erg in GR regulation when treated with a functional inhibitor of
Erg, YK-4-279. In this case, a much lower GR protein expression
was identified in the presence and absence of Dex (Figure A3A in
Appendix). The results showed that despite limited data, Model
4 was still able to reflect the expected experimental observations,
where a low level of Erg was found in CEM-C7–14 cells, to a good
extent. It should be noted that we also identified a depletion of Bim
protein expression when treated with YK-4-279, which suggested a
possible role for Erg in the regulation of Bim (Figure A3 in Appen-
dix). The correlated apoptosis assay with annexin V, however, still
showed an increase in apoptosis, indicating a potential switch to
an alternative apoptotic signaling pathway. More investigation is
required to clarify these results (Chen et al., 2012). Yu et al. (2010)
conducted a detailed study on Erg in the GR subfamily-androgen
receptor (AR) signaling and have shown that Erg may inhibit AR
by a negative autoregulatory loop, or by Erg affecting the AR target
gene selectivity (Chen and Sawyers, 2010). Since AR and GR share
high homology in the DNA binding domain and recognize simi-
lar hormone response elements, the abovementioned mechanism
should be considered in the GR/Erg model (Forman and Samuels,
1990; Laudet et al., 1992).
In the next step, we aimed to determine whether Erg acts as a
direct GR target, as the positive regulation of Erg by GR was only
observed in the resistant C1 cells and a consensus GRE was identi-
fied in Erg. By adapting the direct GR and indirect GR model in C1
cells as indicated in (Chen et al., 2010), two models were created
(Figure 5). GR autoregulation was not considered in resistant C1
cells and the two models only differed by a step of de novo protein
X synthesis. The simulation results showed an induction of GR
and Erg protein and mRNA levels with both Model 5 and Model 6,
with GR protein and Erg mRNA and protein showing a more dra-
matic increase in Model 6 (Figures 6A,B). By observing the trend
and evaluating the residual values, which appeared to fit better
with Model 5 in all cases, we hypothesize that Erg is more likely
to be a direct GR target. Further experimental results are required
to test this prediction. Western blotting of Dex in combination
with YK-4-279 treatment showed a lower Bim expression than
the control in C1 cells (Figure A3B in Appendix), even though a
significant increase in apoptosis was identified previously (Chen
et al., 2012). This suggests that Erg may either be acting as an acti-
vator upstream of anti-apoptotic target genes, or as a repressor of
pro-apoptotic signaling but not via Bim activation.
We have built quantitative models to study c-Jun, Bim, and Erg
signaling and their interactions with GR. Although ODE models
are unable to account for cell-to-cell variability, they are sufficient
to describe and test the major dynamical trends of signaling path-
way components and their interactions. Our models account for
established as well as novel experimental observations regarding
the interplay between GR, c-Jun, and Bim (Model 1 and 2), and
point out how Erg is regulated as a cell specific modulator (Model
3 and 6). Taking the experimental observations into account, this
systems biology approach allowed us to differentiate between alter-
native mechanisms and determine the likely roles of c-Jun and Erg
in the network. Our models can serve as a basis to study GR/c-
Jun/Bim and GR/Erg signaling in ALL and can be continuously
extended as more data become available. Overall, this study shows
that a systems biology approach combining mechanistic modeling
with experimental analysis is of valuable help to dissect complex
signaling pathways and improve our understanding toward disease
and drug action. As modeling allows us to test alternative mech-
anisms and identify more likely scenarios, experimental priorities
can be defined to test the newly generated hypotheses and data sets
can be expanded to increase the computational precision. In the
present study, our models not only reflect the Erg/GR regulation
in C7 cells but also help defining future experimental priorities,
which include: the identification of potential regulatory mecha-
nisms that mediate c-Jun transcription through the analysis of the
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c-Jun promoter for a potential GC sensitive repressor; the use of
cycloheximide and chromatin immunoprecipitation to examine
the interaction between Erg and GR in C1 cells.
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APPENDIX 1
KINETIC EQUATIONS DESCRIBING GR MEDIATED INDUCTION OF BIM, C-JUN, AND ERG
The set of ordinary differential equations describes the GR regulatory kinetics implemented in our models. Here, the kinetics is essen-
tially the same but with different protein or mRNA names. kd_X represents the overall degradation of factor X; k_binding_X is the
regulation between the unknown proteinX and the target gene; k_binding_Erg is the regulation between Erg and GR; k_ligand is the
rate of complex association of dexamethasone and GR; kd_m and kd_p represent the first order rate constants of the degradation of
mRNA and protein respectively. The term Tsl denotes translation, basal denotes basal transcription, proteinX the unknown protein,
and R the glucocorticoid receptor.
APPENDIX 2
MODEL 1 AND 2
GR
d [R_mRNA]
dt
= k_basalR + [R] · k_autoR − [R_mRNA] · kd_mR
d [R]
dt
= [R_mRNA] · k_tslR − [R] · kd_pR
MODEL 1
Bim
d [Bim_mRNA]
dt
= k_basalBim + [Jun] · k_binding_Jun− [Bim_mRNA] · kd_mBim
d [Bim]
dt
= [Bim_mRNA] · k_tslBim− [Bim] · kd_pBim
Jun
d [Jun_mRNA]
dt
= k_basalJun− [Jun_mRNA] · kd_mJun + [Dex] · [R] k_ligand
d [Jun]
dt
= [Jun_mRNA] · k_tslJun− [Jun] · kd_pJun
MODEL 2
Bim
d [Bim_mRNA]
dt
= k_basalBim + [Jun] · k_binding_Jun− [Bim_mRNA] · kd_mBim
d [Bim]
dt
= [Bim_mRNA] · k_tslBim− [Bim] · kd_pBim
Jun
d [Jun_mRNA]
dt
= k_basalJun + [ProteinX_synthesis] · k_binding_X− [Jun_mRNA] · kd_mJun
d [Jun]
dt
= [Jun_mRNA] · k_tslJun− [Jun] · kd_pJun
Frontiers in Physiology | Systems Biology November 2012 | Volume 3 | Article 410 | 12
Chen et al. GR mediated Erg/c-Jun transduction
PROTEIN X SYNTHESIS
d
[
ProteinX_synthesis
]
dt
= [Dex] · [R] · k_ligand− [ProteinX_synthesis] · kd_X
MODEL 3
GR
d [R_mRNA]
dt
= k_basalR + [R] · k_autoR − [R_mRNA] · kd_mR
d [R]
dt
= [R_mRNA] · k_tslR − [R] · kd_pR
Erg
d
[
Erg_mRNA
]
dt
= k_basalErg− [Erg_mRNA] · kd_mErg + [R] · [Dex] · k_ligand
d
[
Erg
]
dt
=
[
Erg_mRNA
] · k_tslErg− [Erg] · kd_pErg
MODEL 4
GR
d [R_mRNA]
dt
= k_basalR + [R] · k_autoR − [R_mRNA] · kd_mR + [Erg_mRNA] · k_binding_Erg
d[R]
dt
= [R_mRNA] · k_tslR − [R] · kd_pR
Erg
d
[
Erg_mRNA
]
dt
= k_basalErg− [Erg_mRNA] · k_dmErg + [R] · [Dex] · k_ligand
d
[
Erg
]
dt
= [Erg_mRNA] · k_tslErg− [Erg] · kd_pErg
MODEL 5
GR
d [R_mRNA]
dt
= k_basalR − [R_mRNA] · kd_mR
d [R]
dt
= [R_mRNA] · k_tslR − [R] · kd_pR
Erg
d
[
Erg_mRNA
]
dt
= k_basalErg− [Erg_mRNA] · kd_mErg + [R] · [Dex] · k_ligand
d
[
Erg
]
dt
= [Erg_mRNA] · k_tslErg− [Erg] · kd_pErg
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MODEL 6
GR
d [R_mRNA]
dt
= k_basalR − [R_mRNA] · kd_mR
d [R]
dt
= [R_mRNA] · k_tslR − [R] · kd_pR
Erg
d
[
Erg_mRNA
]
dt
= k_basalErg− [Erg_mRNA] · k_dmErg + [ProteinX_synthesis] · k_binding_X
d
[
Erg
]
dt
= [Erg_mRNA] · k_tslErg− [Erg] · kd_pErg
PROTEIN X SYNTHESIS
d
[
ProteinX_synthesis
]
dt
= [Dex] · [R] · k_ligand− [ProteinX_synthesis] · kd_X
FIGURE A1 | Flow chart summarizing the workflow described in the introduction.
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Table A1 | Location and sequence of binding sites in the regulatory regions of the indicated genes.
Transcription factor Binding protein Strand Sequence
A. LOCATION AND SEQUENCE OF POTENTIAL GR BINDING SITES IN C-JUN
GR Chr1:59247433–59247449 + AGGTCCATGCAGTTCTT
GR Chr1:59247576–59247595 – TCGTGCACACTGGGGGCGCC
B. LOCATION AND SEQUENCE OF POTENTIAL GR BINDING SITES IN ERG
GR Chr1:40036930–40036946 – CAATAACACGTGGTGAC
Potential GRE sites were identified using the text mining tool –The Champion ChiPTranscription Factor Search Portal (CCTSF) from Qiagen SABiosciences’s database.
(A) Location and sequence of potential GR binding sites in c-Jun. (B) Location and sequence of GR binding sites in Erg.
FIGURE A2 | Proposed regulation of cell death in leukemia. In CEM C7
cells, upon GC treatment, GR becomes activated and alters Bim and GR
transcription, potentially through AP-1 and Erg recruitment respectively. This
may be cell specific as such recruitments were not seen in CEM C1 cells.
Other factors such as MAPK signaling (i.e., JNK or P38) and c-myb may play a
role in regulating GR, AP-1, and Bim.
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FIGURE A3 | GR target gene protein expression in CEM cells.
Western blot analysis of GR, Erg, c-Jun, and Bim protein levels, with
actin as a control in C7 (A) and C1 (B) cells cultured with a combination
of 1µM Dex, 10µM YK-4-279, 10µM JNK inhibitor (SP600125) for 48 h.
Protein levels were quantified by ImageJ, normalized to actin and
presented as a histogram. Error bars represent±SD of two independent
experiments. An asterisk indicates a significant difference at p<0.05
using ANOVA and Tukey’s test.
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